Mergers & Acquisitions
Apr. 11, 2014
Dealmakers
A roundup of recent merger and acquisition and financing activity and the lawyers involved.
Latham advises drugmaker in $5.6B sale
Latham & Watkins LLP advised Anaheim-based pharmaceutical developer Questcor Pharmaceuticals Inc. in its $5.6 billion sale to drugmaker Mallinckrodt Pharmaceuticals PLC, a deal announced Monday.
Under the terms of the deal, Questcor shareholders will receive $30 per share in cash and 0.897 Mallinckrodt shares - amounting to a total consideration of about $86...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In